• Company
• SK Bioscience has started clinical trial of GBP510
• by Chon, Seung-Hyun Sep 2, 2021 05:59am

• Company
• It is necessary to provide Kymriah treatment accessibility
• by Sep 2, 2021 05:59am

• Company
• ‘Somavert’ is reimbursed and starts landing in GHs
• by Eo, Yun-Ho Sep 1, 2021 05:57am

• Policy
• The MOHW objected to improved benefit for Prolia
• by Lee, Jeong-Hwan Sep 1, 2021 05:57am

• Policy
• Lucentis biosimilars have been applied to the MFDS
• by Lee, Tak-Sun Sep 1, 2021 05:57am

• Policy
• DREC to include patient and civic groups' recommendations
• by Lee, Hye-Kyung Sep 1, 2021 05:57am

• Company
• Sales of PARP inhibitor Zejula surpassed Lynparza in 2 years
• by Sep 1, 2021 05:56am

• Company
• GS Cross’s Neulapeg sales jump fivefold in 3 years
• by An, Kyung-Jin Aug 31, 2021 06:14am

• Policy
• MFDS requests supplements for porcine islet transplant trial
• by Lee, Tak-Sun Aug 31, 2021 06:14am

• Company
• Dong-A strengthens line-up with Sanofi's Actonel sales
• by Aug 31, 2021 06:13am